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Abstract
The hemagglutinin-esterases (HEs), envelope glycoproteins of corona-, toro- and orthomyxoviruses, mediate reversible
virion attachment to O-acetylated sialic acids (O-Ac-Sias). They do so through concerted action of distinct receptor-binding
(‘‘lectin’’) and receptor-destroying sialate O-acetylesterase (’’esterase’’) domains. Most HEs target 9-O-acetylated Sias. In one
lineage of murine coronaviruses, however, HE esterase substrate and lectin ligand specificity changed dramatically as these
viruses evolved to use 4-O-acetylated Sias instead. Here we present the crystal structure of the lectin domain of mouse
hepatitis virus (MHV) strain S HE, resolved both in its native state and in complex with a receptor analogue. The data show
that the shift from 9-O-t o4 - O-Ac-Sia receptor usage primarily entailed a change in ligand binding topology and,
surprisingly, only modest changes in receptor-binding site architecture. Our findings illustrate the ease with which viruses
can change receptor-binding specificity with potential consequences for host-, organ and/or cell tropism, and for
pathogenesis.
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Introduction
To initiate infection viruses must bind to an appropriate host
cell. Selectivity of binding is ensured by attachment proteins on the
virion, tailored to recognize one -or at the most- a limited number
of cell surface molecules. Remarkably, a large number of viruses,
representative of at least 11 distinct families several of which of
clinical and/or veterinary importance, use sialic acid (Sia) as
receptor determinant. Owing to differential modification, Sia
structural diversity exceeds that of any other monosaccharide [1].
The most common type of Sia substitution, O-acetylation at
carbon atoms C4, C7, C8 and/or C9, occurs in a host-, organ-
and even cell-specific fashion such that even individual cells of
the same type and tissue may differ in their Sia expression profile
[2–4]. Viruses have evolved to selectively use particular Sia
variants and their attachment proteins are high-specificity
sialolectins, the binding of which might depend on the identity
of the penultimate residue in the sugar chain, the type of glycosidic
linkage and/or the presence or absence of substitutions [5–9].
Ultimately, this preference in Sia receptor usage affects host-,
organ-, and cell-tropism [10–14], the course and outcome of
infection [15–18] as well as the efficacy of intra- and cross-species
transmission [14,19], all to extents not yet fully appreciated.
The hemagglutinin-esterases (HEs) are a class of Sia-binding
envelope glycoproteins found in some negative-stranded RNA
viruses, namely in influenza C and infectious salmon anemia virus
(family Orthomyxoviridae; [5,20]), but also in toro- and coronaviruses,
positive-stranded RNA viruses in the order Nidovirales [21,22].
From phylogenetic and comparative structural analyses it appears
that toro- and coronaviruses acquired their HE proteins separately
via horizontal gene transfer, with an (hemagglutinin-esterase-
fusion) HEF-like protein as progenitor [22–25]. Like influenza C
virus HEF, most nidovirus HEs bind to 9-O-acetylated (9-O-Ac)
Sias and, correspondingly, display sialate-9-O-acetylesterase re-
ceptor-destroying enzyme activity [25]. Murine coronaviruses,
however, occur in two closely related biotypes that differ in HE
ligand/substrate preference. One of these -represented by mouse
hepatitis virus (MHV) strain DVIM- displays the presumptive
ancestral specificity and targets 9-O-Ac-Sias, while the other
-represented by MHV strain S- appears to have evolved to use 4-
O-Ac-Sias instead [6,25–27] (for supplementary introduction see
Text S1 and Figure S1). Given the stereochemical differences
between these Sia variants (Figure 1) and the essentially different
requirements for ligand and substrate recognition by the respective
HEs, the question arises how this major shift in receptor usage was
achieved and what changes must have occurred in the receptor-
binding and O-acetylesterase domains to make this transition
possible.
The crystal structures of a number of 9-O-Ac-Sia-specific
nidovirus HEs have been solved [23,24]. Unlike the receptor-
binding site (RBS) of influenza C virus HEF [28], the RBSs of the
corona- and torovirus HEs seem to be exceptionally plastic as they
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altered their overall architecture in a relatively short evolutionary
time span. Based on these observations, we anticipated and
speculated [23] that this plasticity might have allowed for even
more substantial adjustments in the RBS of the murine cor-
onavirus HE as to produce an entirely novel binding site specific
for 4-O-acetylated Sias.
We now present the crystal structure of the MHV-S HE
receptor-binding domain, both in its native state and in complex
with a receptor analogue. The data reveal in exquisite detail how
the RBS changed to accommodate 4-O- instead of 9-O-acetylated
Sias. Surprisingly, however, this shift in receptor usage seems to
have involved primarily a change in ligand binding topology and
relatively modest changes in RBS architecture.
Results/Discussion
Expression, purification, and biochemical
characterization of MHV-S HE
We produced the ectodomain of MHV-S HE (residues 25-403)
as an Fc-fusion protein, either in enzymatically active (HE-Fc) or
inactive form (HE
0-Fc), by transient transfection of HEK293 cells.
MHV-S HE
0-Fc bound to horse serum glycoproteins (HSG),
which are decorated with 4-O-acetylated sialic acids (4-O-Ac-Sia),
but carry little to no 9-O-Ac-Sias (Figure 2A; [29]). The receptor
determinants in HSG could be destroyed by treatment with
MHV-S HE-Fc, but not by treatment with BCoV-Mebus HE-Fc
(a sialate-9-O-acetylesterase; Figure 2B). No binding of MHV-S
HE
0-Fc was observed to bovine submaxillary mucin (BSM), a
glycoconjugate devoid of 4-O-Ac-Sias (Figure 2A; [30]). The
MHV-S HE ectodomain, released from HE-Fc by thrombin-
cleavage, retained proper sialate-4-O-acetylesterase activity when
assayed for substrate specificity with a synthetic di-O-acetylated Sia
(5-N-acetyl-4,9-di-O-acetylneuraminic acid a-methylglycoside, aN-
eu4,5,9Ac32Me; Figure 2C). In hemagglutination assays, MHV-S
HE
0 specifically bound to 4-O-acetylated Sias (Figure 2D). The
combined findings show that the recombinant MHV-S HE
proteins are biologically active, both as Fc fusion proteins
(Figures 2A and B) and after the removal of the Fc tail by
thrombin-cleavage (Figures 2C and D), which we take as an
indication for proper folding and protein stability.
Figure 1. Stereochemical differences between 9-O- and 4-O-
acetylated sialic acid. Stick representation of (left) aNeu5,9Ac22Me
and (right) aNeu4,5Ac22Me. Backbone aNeu5Ac2Me is colored in gray
(carbon), red (oxygen) and blue (nitrogen). The 9-O-Ac group of
aNeu5,9Ac22Me and 4-O-Ac group of aNeu4,5Ac22Me are highlighted
in cyan (carbon).
doi:10.1371/journal.ppat.1002492.g001
Figure 2. HE-Fc fusion protein displays proper receptor-
binding and enzymatic activities. (A) Binding of two-fold serial
dilutions (starting at 100 mg/ml) of esterase-deficient Fc-fusion proteins
(HE
0-Fc) of BCoV-Mebus and MHV-S in a solid-phase lectin-binding
assay towards horse serum glycoproteins (HSG) and bovine submax-
illary mucins (BSM). Relative binding in percentages is calculated with
the binding of the highest concentration lectin set at a 100%. Wells
incubated without lectin (‘‘mock’’) were included as negative control.
(B) Receptor destroying enzyme activity towards HSG. Coated HSG was
treated with two-fold serial dilutions (starting at 100 ng/ml) of
enzymatically-active BCoV-Mebus and MHV-S HE Fc-fusion proteins
and 4-O-Ac-Sia content was detected by solid phase lectin binding
assay with MHV-S HE
0-Fc. Decrease in signal as compared to untreated
HSG is plotted in percentages. (C) MHV-S HE ectodomain displays
sialate-4-O-acetylesterase activity towards the synthetic di-O-acetylated
sialic acid analogue aNeu4,5,9Ac32Me. Graphs show total ion current
gas-chromatograms and Sia subtypes were identified by mass
spectrometry: Sia (aNeu5Ac2Me [peak 1]), 4-O-Ac-Sia (aNeu4,5Ac22Me
[peak 2]), 9-O-Ac-Sia (aNeu5,9Ac22Me [peak 4], 4,9-di-O-Ac-Sia (aN-
eu4,5,9Ac32Me [peak 5]). Peak 3 represents a non-sialic acid compound.
(D) Receptor binding activity of MHV-S HE ectodomain was assessed by
hemagglutination assay with rat erythrocytes and twofold serial
dilutions of the HE proteins (10,000 to 5 ng per well, arrow).
doi:10.1371/journal.ppat.1002492.g002
Author Summary
Glycans cover the surface of every living cell. In
vertebrates, these sugar trees commonly terminate with
sialic acid (Sia) and, in consequence, Sias have become the
attachment factors of choice for a multitude of pathogens:
protozoa, bacteria and viruses alike. To ensure selectivity,
viruses evolved to target distinct Sia species. Whether a
particular type of Sia serves as receptor may depend -
amongst others- on the absence or presence of specific Sia
modifications. For example, most group A betacorona-
viruses attach to 9-O-acetylated Sias. However, some
murine coronaviruses have switched to using 4-O-acety-
lated Sias instead. In chemical/molecular terms this
represents a momentous shift in receptor usage. We now
have crystallized the hemagglutinin-esterase protein (HE)
of a murine coronavirus and have solved the structure of
its sugar-binding domain. Our findings reveal in exquisite
detail the interactions between Sia binding site and
cognate receptor. The data allow a reconstruction of
how, during coronavirus evolution, the switch in receptor
usage may have come about.
Receptor Binding Site of Murine Coronavirus HE
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Crystals of free MHV-S HE and of a complex of HE
0 with
aNeu4,5Ac22Me diffracted to 2.1 and 2.5 A ˚ resolution, respec-
tively. The structures were solved by molecular replacement by
using BCoV-Mebus HE (PDB ID 3CL5; [23]) as template (BCoV-
Mebus and MHV-S HE share 59% sequence identity; for
crystallographic details, see Table 1).
In overall structure, the HE of MHV-S closely resembles that of
BCoV-Mebus. It assembles into homodimers and the monomers
are composed of three modules: a small membrane-proximal
(MP), a receptor-binding (R), and a central esterase (E) domain
(Figures 3A–C; [23]). The MP domain is virtually identical to that
of BCoV-Mebus HE with a root mean square difference (rmsd) on
main chain Ca atoms of only 0.48 A ˚. Unfortunately, residues in
the E domain, that form the catalytic site were disordered in both
crystals. Hence, the molecular basis for the unusual substrate
specificity of MHV-S HE remains unknown. The structure of the
R domain, however, was resolved, and in the complex the ligand
molecule is well-defined (Figure S2). The R domains of MHV-S
and BCoV-Mebus HE are highly similar with an rmsd on main
chain Ca atoms of 0.79 A ˚.
MHV-S HE has a unique receptor binding-site
The receptor-binding sites of BCoV-Mebus and MHV-S HE
are very much alike in architecture. This is particularly surprising
given the considerable differences in ligand preference and in their
requirements for binding (i.e. binding of 9-O-Ac-Sia in a 9-O-Ac-
dependent fashion versus binding of 4-O-Ac-Sia in 4-O-Ac-
dependent fashion, respectively; Figure 1). The MHV-S HE
receptor-binding site (RBS), like that of BCoV-Mebus HE, is
composed of 5 surface exposed loops, four of which extend from
the conserved 8-stranded ‘‘Swiss role’’ core-structure (loops R1
through R4; Figures 3C and 4A) and one originating from the E-
domain (E-loop). Whereas the R1-, R2- and E-loops of the BCoV-
Mebus and MHV-S HE sites are almost identical, the R3- and R4-
loops adopt different conformations in the two proteins as result of
amino acid insertions in MHV HE (Figures 3C and 4A). Two
other conspicuous elements of the MHV-S HE RBS are the RBS-
hairpin and a conserved metal-binding site with a potassium ion
that stabilizes the R3-loop and the RBS-hairpin exactly as in
BCoV-Mebus HE (Figure 4B). The potassium ion is coordinated
by main chain oxygen atoms of Ser
231, Glu
280 and Leu
282 and side
chain oxygen atoms of Asp
230, Gln
232 and Ser
278. These residues
are conserved in BCoV-Mebus HE and in all other coronavirus
HEs with the exception of HCoV-HKU1 HE [23].
While the overall organization of the MHV-S RBS is similar to
that of BCoV-Mebus HE, the orientation of the receptor analogue
with respect to the RBS is strikingly different (Figures 4B, 5A and
B). As compared to the ligand in the BCoV-Mebus HE binding
site (Figures 5C and D), the aNeu4,5Ac22Me receptor analogue is
rotated by about 90u and shifted by about 2.5 A ˚. Figures 5A and B
show how residues from the four R-loops, the E-loop and the
RBS-hairpin interact with the Sia receptor molecule. Two
hydrogen bonds are formed between the nitrogen and oxygen
main-chain atoms of Lys
217 and the oxygen of the C4 acetyl group
and the nitrogen of the 5-N-acetyl group, respectively. The Ser
220
main chain nitrogen accepts an additional, weak hydrogen bond
from the C8 hydroxyl group of the ligand (Figure 5B).
Most remarkably, the hydrophobic pocket that in BCoV-Mebus
HE accommodates the 9-O-acetyl moiety of the receptor
(comprised of Leu
161, Tyr
184 Leu
266 and Leu
267) -arguably the
most crucial element of the BCoV HE RBS- is conserved in
MHV-S HE (comprised of Ile
166, Tyr
189, Tyr
281, and Leu
282), but
it now accepts the Sia 5-N-acetyl group, while the Sia glycerol side-
chain is solvent exposed (Figure 5A). Moreover, the hydrophobic
patch in the BCoV-Mebus HE RBS that interacts with the Sia 5-
N-acetyl group (Figure 5C) apparently changed into a shallow
pocket that accommodates the Sia 4-O-acetyl moiety (Figure 5A).
The residues orthologous to BCoV-Mebus HE Thr
114, Leu
161,
Phe
211, and Leu
266 were replaced by Leu
119, Ile
166, Ser
216, and
Tyr
281, respectively, and Leu
260 was recruited from the R4-loop,
which in MHV-S HE is reoriented as compared to the one in
BCoV-Mebus HE (Figure 4A). These residues, together with
conserved Phe
212, form the hydrophobic lining of the newly
shaped pocket (Figures 5A and B). As the Sia-4-O-acetyl group is
crucial for ligand recognition by MHV-S HE, this pocket must be
key to receptor-binding. In accordance, single Ala substitutions of
Leu
119, Ile
166, Phe
212, Leu
260, or Tyr
281 all reduced receptor-
binding activity (although that of Ile
166 to lesser extent) as shown
by hemagglutination assay (Figure 5E) and solid-phase lectin
binding assay (Figure 5F).
Relatively modest changes in the MHV-S receptor
binding-site changes ligand specificity
The data reveal in minute detail not only the mode of inter-
action between MHV-S HE and its cognate receptor determinant,
Table 1. Data collection and refinement statistics.
MHV-S HE
MHV-S HE
0
with ligand
Data collection
Spacegroup P212121 P212121
Cell dimensions a,b,c (A ˚) 92.8,108.8,125.1 91.6,106.6,135.6
a,b,c (
o) 90.0, 90.0, 90.0 90.0, 90.0, 90.0
Resolution (A ˚)* 30-2.1 54.5-2.5
(2.22-2.10) (2.64-2.50)
Completeness (%) 99.5 (96.8) 100.0 (100.0)
#Unique reflections 73858(10352) 46670(6706)
Multiplicity 7.4(7.4) 7.4 (7.4)
Rmerge (%) 10.3 (70.1) 12.2 (90.2)
I/s 12.9 (2.9) 12.7 (2.1)
Refinement
Rwork/Rfree
{ (%) 18.8/22.2 21.3/24.9
#Protein atoms
{ 5676 5457
#Glycan units 31 28
#Waters 291 77
Mean B value protein (A ˚2) 33.4 28.8
Mean B value water (A ˚2) 38.5 28.4
Rmsd bond lengths (A ˚) 0.010 0.009
Rmsd bond angles (u) 1.3 1.2
Ramachandran plot
Favored regions (%) 94.6 95.0
Allowed regions (%) 4.7 4.4
Disallowed regions (%) 0.7 0.6
*Values between brackets refer to the highest resolution shell of data.
{Rfree is calculated from 5% of data randomly chosen not to be included in
refinement.
{Two HE molecules are present in the asymmetric unit of the crystal; during
refinement no NCS restraints were applied.
doi:10.1371/journal.ppat.1002492.t001
Receptor Binding Site of Murine Coronavirus HE
PLoS Pathogens | www.plospathogens.org 3 January 2012 | Volume 8 | Issue 1 | e1002492Figure 3. Overall structure and comparison to BCoV-Mebus HE. (A) Ribbon representation of the dimeric MHV-S (residues 25–395) and BCoV-
Mebus HE (residues 19–376) structures. One monomer is colored grey, the other by domain: lectin domain (R, blue) with bound aNeu4,5Ac22Me
(MHV-S HE) or aNeu4,5,9Ac32Me (BCoV-Mebus HE; cyan sticks) and potassium ion (magenta sphere); esterase domain (E, green); membrane-proximal
domain (MP, red). (B) Linear representation of MHV HE with domains color-coded as in panel A. Grey segments indicate the signal-peptide (SP) and
transmembrane (TM) domain. The bracket indicates the part of the protein for which the structure has been solved. (C) Structure- (MHV-S and BCoV-
Mebus) and sequence-based (MHV-DVIM) alignment of HE sequences. Colored boxes above the sequences indicate domain organization as in panel
A and B and black lines indicate loops involved in receptor binding. Note that in MHV-S HE two insertions increase the length of loops R3 and R4.
Asterisks indicate the highly conserved residues of the potassium binding site and boxes indicate the critical serine, histidine and aspartic acid
residues of the catalytic site. Residues that interact with the ligand are indicated in bold; those conserved among all three HEs are highlighted by grey
shading. Other residues also conserved in all three HEs are highlighted in yellow. The residues in disordered loops of the esterase domain are
indicated in light gray lettering.
doi:10.1371/journal.ppat.1002492.g003
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transformed into one that now specifically binds 4-O-Ac-Sia. The
most striking observation is that this major shift in ligand
specificity required only minimal changes in the protein and that
the binding site architecture was essentially maintained. How this
was possible can be explained from the mode of lectin-ligand
interaction, based largely on the docking of the methyl groups of
the Sia-acetyl moieties into hydrophobic pockets, and from the
structures of the two types of ligands. The juxtaposition of the Sia
5-N- and 9-O-acetyl moieties is quasi-similar to that of the Sia 4-O-
and 5-N-acetyl groups. The distance between the groups may be
different (7.1 versus 5.7 A ˚ as measured between the methyl carbon
atoms, respectively), but for each combination the acetyl groups
are located in roughly the same plane and at roughly similar angles
(Figure S3). Thus, it can be envisaged that a pre-existing site for 9-
O-Ac-Sia was converted to accommodate 4-O-Ac-Sia instead by (i)
having the ligand rotate (with binding of the ligand in the novel
orientation facilitated through hydrogen bonding with residues
introduced by substitutions and/or insertions in the R3 loop) and
(ii) by bringing the original 9-O-acetyl binding pocket and 5-N-
acetyl binding patch more closely together so that they now can
accept the 5-N- and 4-O-acetyl moieties, respectively (Figure S3).
From attempts to fit aNeu5,9Ac22Me into the MHV-S RBS by in
silico modelling, the the 9-O- and 5-N-acetyl groups would seem to
be spaced too far apart to conveniently dock into the acetyl-
binding pockets. Moreover, were the ligand to bind in this
orientation, the Sia carboxylate would clash with the modified R3-
loop. These findings thus provide an explanation for exclusion of
the original ligand and for the specificity of MHV-S HE for 4-O-
Ac-Sias (Figure S3 and Video S1).
The structure of the MHV-S HE-receptor complex allows
guarded predictions only of how glycosidic linkage or additional
Sia modifications might affect ligand binding. The C2-oxygen
through which glycosidically-bound Sia would be linked to the
penultimate residue of the glycan chain is exposed to the solvent
and we would therefore expect the lectin to bind Sias in a linkage-
independent fashion. Still, the R4- and/or E-loops, as they are
proximal to Sia C2 (Figure 4A), might affect ligand binding such as
to cause a preference for a particular linkage type. The pocket for
the Sia 5-N-acetyl group would seem sufficiently wide to also
accommodate the slightly larger 5-N-Gc substituent (Figure 5A);
whether the lectin does accept 5-N-glycolylated Sias as ligands
remains to be shown, however. Finally, from the topology and
orientation of aNeu4,5Ac22Me in the RBS of MHV-S HE, ligand
binding would seem to be tolerant to modifications at the Sia
glycerol side chain (Figure 5A). Yet, as demonstrated by
hemagglutination assay with native and sialate-9-O-acetylester-
ase-treated erythrocytes, MHV-S HE apparently prefers 4-mono-
O- over 4,9-di-O-acetylated Sias [27].
The occurrence of two distinct MHV lineages –exemplified by
strains S and DVIM– that through their HE proteins bind to
Figure 5. MHV-S HE has a unique receptor-binding site that
binds specifically 4-O-acetylated sialic acid. (A) Surface and (B)
stick representation of the MHV-S HE receptor-binding site in complex
with a receptor analogue. The ligand bound to the HE receptor-binding
site is shown in stick representation and the potassium ion as a
magenta sphere, indicated by a black arrow in panel A. Hydrogen
bonds between HE and the receptor are shown as black dashed lines.
Surface representation of the MHV-S HE receptor-binding site reveals
two pockets accommodating the 4-O- and 5-N-acetyl groups of the
receptor, respectively. Note that crystals were soaked with aN-
eu4,5,9Ac32Me, but most likely as a result of the low pH crystallization
conditions, the 9-O-Ac group was lost [42]. (C) Surface and (D) stick
representation of the BCoV-Mebus HE receptor-binding site. Note that
the topology of the two hydrophobic pockets is conserved, except they
bind different substituents of the receptor analogue. (E) The effect of
Ala substitutions on receptor binding. Relative binding affinity of wild-
type HE
0 (wt) and its derivatives was assessed by hemagglutination
assay with rat erythrocytes and twofold serial dilutions of each of the
HE
0-Fc chimeras (5,000 to 10 ng per well, arrow). (F) Binding of twofold
serial dilutions of wild-type (wt) HE
0-Fc chimera and its derivatives in a
solid-phase lectin-binding assay towards horse serum glycoproteins
(HSG) as described in Figure 2A.
doi:10.1371/journal.ppat.1002492.g005
Figure 4. Comparison of the MHV-S and BCoV-Mebus HE
receptor binding sites. (A) Ribbon superposition of the MHV-S and
BCoV-Mebus HE receptor binding sites. BCoV-Mebus HE is colored gray,
coloring of MHV-S HE as in panel A. Bound receptor analogues are
shown as cyan sticks and potassium ions as magenta spheres. The five
surface exposed loops and the RBS-hairpin that interact with the
receptor are indicated. Note that only the R3- and R4-loops differ in
conformation. (B) Close-up of the HE-potassium binding-site of MHV-S
HE and BCoV-Mebus HE. Shown in ribbon representation are the R3-
loop (salmon) and RBS-hairpin (purple) that interacts with the
potassium ion (magenta sphere).
doi:10.1371/journal.ppat.1002492.g004
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While the structure reported here provides clues to how an HE
protein ancestral to that of MHV-S may have changed to bind to
4-O- rather than to 9-O-acetylated Sias, the conditions that
selected for this shift in ligand specificity and the biological
consequences thereof are unknown. The limited data available on
the in vivo role of HE suggests that it promotes viral spread [31].
Entry of murine coronaviruses, however, is mediated not by HE,
but by the S protein, a type I fusion protein that binds to the
principal receptor CAECAM1a [32–34]. We propose that HE
may act during the very early stages of the infectious cycle as a
molecular timer for temporary virion attachment. Through the
concerted actions of its lectin and sialate-O-acetylesterase domains,
HE would allow virus particles to bind with high avidity and yet
reversibly to sialylated surfaces. The time allowed for virions to
remain attached would be a function of HE binding affinity/
avidity, esterase activity and local Sia density. Virions by binding
to the ubiquitous and highly accessible Sias in the glycocalix would
buy time for the S protein to find and bind the main receptor at
the cell’s surface as an obligatory prelude to penetration. Such a
strategy would be advantageous particularly under conditions of
low receptor density or poor receptor accessibility. If within the
allotted time, HE-mediated virion attachment would not progress
to this next stage of entry (for example, because the particle
attached not to a susceptible cell, but to decoy receptors on a non-
cell-associated glycoconjugate), the default would be for the virus
to elute and ‘‘take its business elsewhere’’. In this model, , MHV
HE would appreciably contribute to host cell selection, its ligand
preference potentially affecting host-, organ- and cell tropism. Our
findings pave the way to study the function of CoV HE and to
assess the importance of ligand and substrate specificity through an
approach of structure-guided mutagenesis, reverse genetics and
animal experimentation in a natural infection model.
Materials and Methods
Protein expression and purification
A synthetic DNA with human codon-optimized sequence for
the HE ectodomain of MHV strain S (MHV-S; amino acid
residues 25–403) was cloned in pCD5-Ig [23,24], a derivative of
expression plasmid S1-Ig [35]. The resulting construct, pCD5-
MHV-S-HE-T-Fc, codes for a chimeric HE protein provided with
an N-terminal CD5 signal peptide and, at its C-terminus,
preceded by a thrombin cleavage site, the Fc domain of human
IgG1 (HE-Fc). The QuikChange XL II site-directed mutagenesis
kit (Stratagene) was used to construct pCD5-MHV-S-HE-T-Fc
derivatives that code for an enzymatically inactive HE-Fc with the
esterase catalytic residue Ser
45 replaced by Ala (HE
0-Fc), and for
HE
0-Fc mutants with Ala substitutions in the receptor-binding site.
For analytical purposes, HE-Fc fusion proteins were produced by
transient expression in HEK293T cells and then purified from the
cell culture supernatants by protein A-affinity chromatography
and low-pH elution (0.1M Citric-acid pH 3.0). The pH of the
eluate was neutralized by adding Tris pH 8.0 to a final
concentration of 0.2 M and the protein solution was dialyzed
against phosphate-buffered saline (PBS). For crystallography, HE-
Fc fusion-proteins were transiently expressed in HEK293 GnTI(-)
cells [36] and the MHV-S ectodomain was purified by protein A-
affinity chromatography and on-the-beads thrombin cleavage as
described [23,24].
Solid-phase lectin binding assay (SLBA)
Maxisorp 96-well plates (NUNC) were coated for 16 hrs at 4uC
with horse serum glycoproteins (HSG; 10% v/v horse serum in
PBS) or bovine submaxilary mucin (BSM; 10 mg/ml; Sigma) at
100 ml per well. The wells were washed with washing buffer (PBS,
0.05% Tween-20) and treated with blocking buffer (PBS, 0.05%
Tween-20, 2% bovine serum albumin, BSA) for 1 hr at RT. Two-
fold serial dilutions of HE
0-Fc lectins were prepared in blocking
buffer (starting concentration 100 mg/ml) and 100 ml samples of
these dilutions were added to the glycoconjugate-coated wells.
Incubation was continued for 60 min after which unbound lectin
was removed by washing three times. Bound lectin was detected
using an HRP-conjugated goat anti-human IgG antiserum
(1:10,000 in blocking buffer; Southern Biotech) and TMB Super
Slow One Component HRP Microwell Substrate (BioFX)
according to the instructions. The staining reaction was terminat-
ed by addition of 0.3 M phosphoric acid, the optical density was
measured at 450 nm, and graphs were constructed using
GraphPad software. To assess and compare the enzymatic
activities of BCoV-Mebus and MHV-S HE-Fc towards 4-O-
acetylated Sias, HSG coated in Maxisorp plates was treated with
samples from two-fold serial dilutions of either enzyme (starting at
100 ng/ml in PBS, 100 ml/well) for 2 hrs at 37uC. The destruction
of 4-O-Ac-Sia receptor determinants was determined by SLBA
with MHV-S HE
0-Fc (5 mg/ml in blocking buffer) as described
above. Enzymatic de-O-acetylation of aNeu4,5,9Ac32Me was
analyzed by gas-chromatography-electron impact mass-spectrom-
etry (GC-MS) as described [24,25,37].
Hemagglutination assay
Hemagglutination assay was performed in V-shaped 96-well
plates (Greiner Bio-One). Two-fold serial dilutions in 50 ml PBS,
0.1% BSA of HE
0-Fc or of purified HE
0 ectodomains (starting
amounts indicated in the text) were mixed with 50 ml of a rat
erythrocyte suspension (Rattus norvegicus strain Wistar; 0.5% in PBS)
and incubated for 2 hours on ice.
Crystallization
Crystallization conditions were screened by the sitting-drop
vapor diffusion method using a Honeybee 961 (Genomic
Solutions). Drops were set up with 0.2 ml of HE protein solution
in 10 mM Tris-HCl pH 8.0 and 0.2 ml reservoir solution. Crystals
with space group P212121 were obtained from 0.2 M KH2PO4, 0.2
M sodium malonate, 15% (w/v) PEG3350 and 0-5% (w/v)
glycerol at 18uC. Crystals for diffraction experiments were grown
with the hanging drop vapor diffusion method set up by hand with
reservoir and protein solution ratio 1:1 (1.6 ml total) at 18uC, and
grew to a final size of up to 0.2560.2060.20 mm within one week.
For data collection, crystals were flash-frozen in liquid nitrogen
using reservoir solution containing 20% (w/v) glycerol as the
cryoprotectant. To determine the HE structure in complex with its
receptor, crystals of HE
0 were soaked by adding 2 mlo f1 0m M
aNeu4,5,9Ac32Me in cryoprotectant solution directly into the
margin of the drop, resulting in a final substrate concentration of
about 7 mM. Crystals were flash-frozen after 5 to 10 minutes.
Data collection and structure solution
Diffraction data of crystals of MHV-S HE and its complex
(Table 1) were collected at ESRF station ID-14-1 and ID-14-3,
respectively. Diffraction data of native and ligand-soaked HE
crystals were processed using XDS [38] and scaled using SCALA
from the CCP4 suite [39]. Molecular replacement was performed
using PHASER with BCoV-Mebus HE as template (PDB ID:
3CL5; [23]). Models were built manually with Coot [40] and
refinement was carried out using REFMAC [41]. Water molecules
were added using ARP/WARP, graphics generated with PYMOL
(http://pymol.sourceforge.net).
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disallowed regions. The electron density of these residues supports
the modeled conformation. In both HE monomers present in the
asymmetric unit of the crystal structure of free as well as ligand-
bound HE, the active site region of the esterase domain is largely
disordered. No electron density is observed for esterase domain
residues A52-A59, B51-B59, A108-A114, A308-A314, A335-A347
and B338-B346, while residues 44-50, 60-72, 332-334, and 348-
358 adopt different conformations in the two monomers.
Modeling of chain A residues 397-401 and chain B residues
334-337 and 394-398 should be considered tentative. C-terminal
residues 396-403 followed by the 7-residue thrombin recognition
sequence of the cleavable Fc-fusion are stabilized by crystal
packing interactions suggesting that the observed conformation is
not physiologically relevant.
Supporting Information
Figure S1 Rooted Neighbor-Joining tree depicting the
evolutionary relationships among coronavirus HE pro-
teins with Influenza C virus (IFC) HEF as outgroup.
Confidence values calculated by bootstrapping (1000 replicates)
are indicated at the major branching points. HEs specific for 9-O-
acetylated Sia as determined on the basis of their lectin ligand
specificity and/or sialate-O-acetylesterase substrate preference are
high-lighted in green, the one specific for 4-O-acetylated Sia in red.
HCoV, human coronavirus; PHEV, porcine hemagglutinating
encephalomyelitis virus, EqCoV, equine coronavirus.
(TIF)
Figure S2 Electron density of the receptor. (A) Difference
electron density map calculated from the final model from which
the ligand had been omitted. The contour level is 3.0 s. (B) 2Fo-Fc
map of the final model contoured at the 1.0 s level.
(TIF)
Figure S3 A large shift in ligand specificity through
modest changes in receptor-binding site architecture. (A)
Stick representation of aNeu4,5,9Ac32Me in gray with (left) the 5-
N-Ac- and 9-O-Ac- or (right) the 4-O-Ac- and 5-N-Ac-groups
colored in red (oxygen), blue (nitrogen) and cyan (carbon). Arrows
indicate the distances between Ac methyl groups and asterisks the
position of the O2 atom through which Sia would be linked to the
penultimate residue of the glycan chain. The patch that
accommodates the Sia-5-N-Ac group in BCoV-Mebus HE, and
the newly formed pocket that accommodates the Sia-4-O-Ac group
in MHV-S HE are colored in cyan. The pockets that harbor the
Sia-9-O-Ac group in BCoV-Mebus HE and now accommodates
the Sia-5-N-Ac group in MHV-S HE are colored in green. (B)
Surface representation of the MHV-S HE receptor binding site
with Neu5,9Ac22Me modeled in silico in a topology corresponding
to that in BCoV HE. The model predicts that 9-O-Ac-Sia will not
be accepted as ligand because of (i) the spatial arrangement of the
two hydrophobic pockets at too close a distance of each other and
(ii) a clash of the Sia carboxylate with residues of the extended R3
loop.
(TIF)
Text S1 Supplementary introduction; Receptor switch-
ing from 9-O-t o4 - O-Ac-Sias or the other way around?
(DOC)
Video S1 A large shift in ligand specificity through
modest changes in receptor-binding site architecture.
Only a few changes in the receptor binding site architecture of the
MHV-S HE protein resulted in the specific binding of 4-O-
acetylated sialic acid and the exclusion of 9-O-acetylated sialic
acid.
(WMV)
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